Alnylam Pharmaceuticals, Inc. (ALNY): Shareholders' Equity
$789.18M
As of 2025-12-31
$1.35B
As of 2026-06-30
-4.9%
5-year compound annual growth
-4.6%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $789.18M | n/m | 2026-02-12, Balance as of period end |
| 2024-12-31 | $67.09M | n/m | 2026-02-12, Balance as of period end |
| 2023-12-31 | -$220.64M | n/m | 2026-02-12, Balance as of period end |
| 2022-12-31 | -$158.22M | n/m | 2025-02-13, Balance as of period end |
| 2021-12-31 | $588.20M | -42.1% | 2024-02-15, Balance as of period end |
| 2020-12-31 | $1.02B | -29.4% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $1.44B | +10.5% | 2022-02-10, Balance as of period end |
| 2018-12-31 | $1.30B | -26.3% | 2021-02-11, Balance as of period end |
| 2017-12-31 | $1.77B | +92.0% | 2020-02-13, Balance as of period end |
| 2016-12-31 | $920.22M | -27.2% | 2019-02-14, Balance as of period end |
| 2015-12-31 | $1.26B | +35.1% | 2018-02-15, Balance as of period end |
| 2014-12-31 | $936.27M | +246.3% | 2017-02-15, Balance as of period end |
| 2013-12-31 | $270.35M | +101.7% | 2016-02-12, Balance as of period end |
| 2012-12-31 | $134.05M | +13.6% | 2015-02-13, Balance as of period end |
| 2011-12-31 | $118.00M | -25.4% | 2014-02-20, Balance as of period end |
| 2010-12-31 | $158.23M | -11.1% | 2013-02-19, Balance as of period end |
| 2009-12-31 | $177.97M | -12.0% | 2012-02-13, Balance as of period end |
| 2008-12-31 | $202.12M | n/a | 2011-02-18, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.94B | -32.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.32B | +5.5% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $9.71B | -6.1% |
Compare ALNY, PRGO, JAZZ, BMRN side by side · Screen every company in Pharmaceutical Preparations ↗